Life Sciences Has Lagged; Morningstar Likes These Biotech Stocks
Life-science stocks have struggled this year, with the iShares Biotechnology ETF suffering a negative return of 0.64%. The stocks' struggles have put them on average at a discount…
Life-science stocks have struggled this year, with the iShares Biotechnology ETF suffering a negative return of 0.64%. The stocks' struggles have put them on average at a discount…
